These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1746663)

  • 41. An analysis of the effects of HIV infection in a cohort of intravenous drug users.
    O'Kelly FD; Bury G
    Ir Med J; 1996; 89(3):112-4. PubMed ID: 8707519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HIV risks in a homeless population.
    Lee D; Ross MW; Mizwa M; Scott DP
    Int J STD AIDS; 2000 Aug; 11(8):509-15. PubMed ID: 10990335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk factors for HIV infection in homosexual men: the Cleveland men's study of risks in a low-prevalence area.
    Smucny J; Hom D; Ellner JJ; Carey JT; Houser HB; Calabrese LH; Edmonds K; Bowerfind E; Proffitt M; Yen-Lieberman B
    Cleve Clin J Med; 1992; 59(6):573-80. PubMed ID: 1424067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The homosexual transmission of HIV/AIDS in Mexico].
    Izazola-Licea JA; Avila-Figueroa RC; Gortmaker SL; del Río-Chiriboga C
    Salud Publica Mex; 1995; 37(6):602-14. PubMed ID: 8599134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for HIV seropositivity in a sample of drug users in drug treatment in Ho Chi Minh City, Vietnam.
    Tran SD; Williams AB; Truong HT; Do NH
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):283-7. PubMed ID: 9495230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users.
    Alcabes P; Muñoz A; Vlahov D; Friedland G
    Ann Epidemiol; 1994 Jan; 4(1):17-26. PubMed ID: 7911376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for human immunodeficiency virus infection in 581 intravenous drug users, northeast Italy, 1984-1988. The AIDS and Related Syndromes Study Group.
    Serraino D; Franceschi S; Vaccher E; Diodato S; Santini GF; La Vecchia C; Hayes R; Tirelli U
    Int J Epidemiol; 1991 Mar; 20(1):264-70. PubMed ID: 2066233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV infection and AIDS in China, 1985 through 1994.
    Yu ES; Xie Q; Zhang K; Lu P; Chan LL
    Am J Public Health; 1996 Aug; 86(8):1116-22. PubMed ID: 8712271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Developing surveillance for HIV transmission and risk behaviours among high-risk groups in a central London health district.
    Nardone A; Mercey D; Johnson AM; McCarthy M
    J Public Health Med; 1999 Jun; 21(2):208-14. PubMed ID: 10432252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample.
    Zolopa AR; Hahn JA; Gorter R; Miranda J; Wlodarczyk D; Peterson J; Pilote L; Moss AR
    JAMA; 1994 Aug; 272(6):455-61. PubMed ID: 8040981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Seroprevalence of HIV and risk behaviors among young homosexual and bisexual men. The San Francisco/Berkeley Young Men's Survey.
    Lemp GF; Hirozawa AM; Givertz D; Nieri GN; Anderson L; Lindegren ML; Janssen RS; Katz M
    JAMA; 1994 Aug; 272(6):449-54. PubMed ID: 8040980
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
    Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
    JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.
    van Ameijden EJ; van den Hoek JA; van Haastrecht HJ; Coutinho RA
    Am J Epidemiol; 1992 Jul; 136(2):236-43. PubMed ID: 1415145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV prevalence and HIV risk behaviour among injecting drug users in London and Glasgow.
    Rhodes TJ; Bloor MJ; Donoghoe MC; Haw S; Ettore B; Platt S; Frischer M; Hunter GM; Taylor A; Finlay A
    AIDS Care; 1993; 5(4):413-25. PubMed ID: 8110856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV risk factors and seroprevalence in surgical patients.
    Reid CB; Kaldor JM; Lord RS; Cooper DA
    Med J Aust; 1993 Jan; 158(1):21-3. PubMed ID: 8417285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV infection among female injection-drug users recruited in community settings.
    Watters JK; Estilo MJ; Kral AH; Lorvick JJ
    Sex Transm Dis; 1994; 21(6):321-8. PubMed ID: 7871445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk dimensions of HIV-tested substance users.
    Ottomanelli G
    Int J Addict; 1993 Dec; 28(14):1487-95. PubMed ID: 8307661
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioid Use Fueling HIV Transmission in an Urban Setting: An Outbreak of HIV Infection Among People Who Inject Drugs-Massachusetts, 2015-2018.
    Alpren C; Dawson EL; John B; Cranston K; Panneer N; Fukuda HD; Roosevelt K; Klevens RM; Bryant J; Peters PJ; Lyss SB; Switzer WM; Burrage A; Murray A; Agnew-Brune C; Stiles T; McClung P; Campbell EM; Breen C; Randall LM; Dasgupta S; Onofrey S; Bixler D; Hampton K; Jaeger JL; Hsu KK; Adih W; Callis B; Goldman LR; Danner SP; Jia H; Tumpney M; Board A; Brown C; DeMaria A; Buchacz K
    Am J Public Health; 2020 Jan; 110(1):37-44. PubMed ID: 31725317
    [No Abstract]   [Full Text] [Related]  

  • 59. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation.
    Friedman SR; Kottiri BJ; Neaigus A; Curtis R; Vermund SH; Des Jarlais DC
    Am J Epidemiol; 2000 Nov; 152(10):913-22. PubMed ID: 11092433
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maternal-newborn human immunodeficiency virus infection in Harlem.
    Nicholas SW; Bateman DA; Ng SK; Dedyo T; Heagarty MC
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):813-9. PubMed ID: 8044255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.